Warsaw, Poland

Molecure S.a.


USPTO Granted Patents = 6


Forward Citations = 1

Loading Chart...
Loading Chart...

40 inventors (with patents filed for the assignee):

goldMedal Krzysztof Matyszewski (3 out of 7 patents)

silverMedal Marzena Mazur (3 out of 7 patents)

bronzeMedal Robert Koralewski (3 out of 7 patents)

4.  Sylwia Olejniczak (3 out of 8 patents)

5.  Anna Gzik (2 out of 6 patents)

6.  Bartlomiej Borek (2 out of 9 patents)

7.  Jacek Chrzanowski (2 out of 3 patents)

8.  Wojciech J Czestkowski (2 out of 6 patents)

9.  Agnieszka Bartoszewicz (2 out of 5 patents)

10.  Piotr Niedziejko (2 out of 2 patents)

11.  Grzegorz Witkowski (2 out of 2 patents)

12.  Magdalena Tyszkiewicz (2 out of 2 patents)

13.  Marta Magdycz (2 out of 2 patents)

14.  Marcin Zakrzewski (2 out of 2 patents)

15.  Adam Golebiowski (2 out of 2 patents)


6 patents:

Company Overview
Molecure S.a. is a biopharmaceutical company focused on the discovery and development of innovative therapies for the treatment of cancer and other serious diseases. The company leverages advanced molecular technologies to create targeted treatments that aim to improve patient outcomes. With a commitment to scientific excellence and collaboration, Molecure is dedicated to addressing unmet medical needs through its robust pipeline of drug candidates and strategic partnerships in the pharmaceutical industry.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#19 in Warsaw

#54 in Poland

Warsaw, PL
Warsaw, Poland
Forward Citations = 1

40 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Molecure S.a.. Retrieved from https://idiyas.com/company/molecure-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…